PRESS RELEASE Bridgeater, New Jersey :Amneal today announced the creation of Amneal Biosciences, a wholly-possessed subsidiary of Amneal Pharmaceuticals LLC . Amneal Biosciences shall focus solely on the commercialization of high-barrier-to-access generic and specialty pharmaceuticals such as for example injectables, oncologics and biosimilars to healthcare providers globally. Having a dedicated company focused on the unique needs and logistics of this market segment allows Amneal to ensure the same quality level and service to healthcare institutions and specialists that we deliver to our existing retail clients, explains Amneal co-CEO and Chairman Chirag Patel.

Other Articles From "diabetology":

Random Articles